BSX

Boston Scientific Corp

Jan 23 • 04:00PM ET

92.51

+1.22 1.34 %

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO IVV SPY VUG XLV IHI VHT IWD SPYM

Index	S&P 500	P/E	49.48	EPS (ttm)	1.87	Insider Own	0.39%	Shs Outstand	1.48B	Perf Week	2.75%
Market Cap	137.19B	Forward P/E	26.62	EPS next Y	3.47	Insider Trans	-4.42%	Shs Float	1.48B	Perf Month	-4.07%
Enterprise Value	148.10B	PEG	1.64	EPS next Q	0.78	Inst Own	93.39%	Short Float	1.35%	Perf Quarter	-10.92%
Income	2.79B	P/S	7.09	EPS this Y	20.97%	Inst Trans	0.42%	Short Ratio	2.11	Perf Half Y	-12.90%
Sales	19.35B	P/B	5.86	EPS next Y	14.44%	ROA	6.91%	Short Interest	20.01M	Perf YTD	-2.98%
Book/sh	15.78	P/C	99.92	EPS next 5Y	16.28%	ROE	12.66%	52W High	109.50 -15.52%	Perf Year	-7.78%
Cash/sh	0.93	P/FCF	35.88	EPS past 3/5Y	21.99% -17.84%	ROIC	7.99%	52W Low	85.98 7.59%	Perf 3Y	105.17%
Dividend Est.	-	EV/EBITDA	30.86	Sales past 3/5Y	12.10% 9.30%	Gross Margin	62.57%	Volatility	2.74% 2.01%	Perf 5Y	154.64%
Dividend TTM	-	EV/Sales	7.65	EPS Y/Y TTM	54.80%	Oper. Margin	17.82%	ATR (14)	2.29	Perf 10Y	409.42%
Dividend Ex-Date	-	Quick Ratio	0.96	Sales Y/Y TTM	21.62%	Profit Margin	14.43%	RSI (14)	44.22	Recom	1.24
Dividend Gr. 3/5Y	- -	Current Ratio	1.51	EPS Q/Q	60.10%	SMA20	-2.12%	Beta	0.67	Target Price	125.16
Payout	0.00%	Debt/Eq	0.51	Sales Q/Q	20.34%	SMA50	-4.02%	Rel Volume	1.43	Prev Close	91.29
Employees	53000	LT Debt/Eq	0.49	Earnings	Feb 04 BMO	SMA200	-7.98%	Avg Volume	9.49M	Price	92.51
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.09% 1.93%	Trades		Volume	13,612,547	Change	1.34%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55

Show Previous Ratings

Today 11:43AM	ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Jan-22-26 09:52PM	Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance (Insider Monkey)
12:32PM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
Jan-21-26 07:07PM	J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll (Investor's Business Daily)
12:30PM	Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface (Benzinga)
10:49AM	Loading…
10:49AM	CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February (Zacks)
08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
07:58AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-20-26 01:39PM	Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now? (Zacks)
08:36AM	Should You Still Hold GMED Stock in Your Portfolio? (Zacks)
05:52AM	3 takeaways from Boston Scientifics $14.5B Penumbra deal (MedTech Dive)
Jan-19-26 12:34PM	SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal (Zacks)
12:31PM	Here's Why You Should Hold DaVita Stock in Your Portfolio for Now (Zacks)
10:10AM	Podcast: JPM26s dealmaking falls short of expectations (Pharmaceutical Technology)
08:46AM	Loading…
08:46AM	AI, Digital Tools and Hub Data: Could ISRG Evolve Beyond Robotics? (Zacks)
07:38AM	Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan (Zacks)
Jan-18-26 06:16AM	Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth (Insider Monkey)
Jan-16-26 03:54PM	Deal Dispatch: From $14B Medtech Buys To Vodka Bankruptcies, This Week's M&A Roundup (Benzinga)
12:46PM	Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results (Zacks)
12:42PM	DexCom Stock Declines Following Strong Preliminary Q4 Results (Zacks)
12:12PM	This is Why Wall Street Firms are Bullish on Boston Scientific Corporation (BSX) (Insider Monkey)
09:35AM	Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround (Zacks)
07:18AM	Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening (Zacks)
Jan-15-26 06:34PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
05:34PM	Podcast: Chips, Banks Boost Markets (The Wall Street Journal)
04:33PM	Stocks Boosted by Chip Demand Optimism (Barchart)
04:25PM	Stocks to Watch Thursday: Penumbra, BlackRock, Goldman Sachs (The Wall Street Journal)
04:16PM	Lightning Flashes As Boston Scientific Takes Over Penumbra For $14.5 Billion (Investor's Business Daily)
01:23PM	JPM26: Boston Scientific acquires Penumbra in $14.5bn deal (Medical Device Network)
01:11PM	Loading…
01:11PM	Wall Street Soars Near Records, AMD And ASML Jump 6%: What's Moving Markets Thursday? (Benzinga)
12:51PM	Why Boston Scientific (BSX) Stock Is Down Today (StockStory)
11:51AM	Half of GLP-1 users ditch their injections - and some are turning to other weight-loss methods instead (MarketWatch)
10:53AM	Masimo Stock Declines Despite Solid Preliminary Q4 Revenues (Zacks)
10:37AM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
10:35AM	PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research (Zacks)
10:17AM	Boston Scientific Agrees to Buy Penumbra in $14.6 Billion Cardiovascular Deal (GuruFocus.com)
09:42AM	Phibro Animal Health Stock Climbs 90.9% in a Year: What's Driving It? (Zacks)
09:42AM	Is it Apt to Retain HAE Stock in Your Portfolio for Now? (Zacks)
09:37AM	Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock (The Wall Street Journal)
09:23AM	BlackRock earnings, Spotify to raise premium price in the US (Yahoo Finance Video)
08:45AM	Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. (Barrons.com)
08:42AM	Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy (Benzinga)
08:38AM	Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down (Investing.com)
08:24AM	BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies (Zacks)
08:11AM	Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to 'fast-growing' vascular segments (MarketWatch)
07:23AM	Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal (Investor's Business Daily)
07:19AM	Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock (The Wall Street Journal)
07:13AM	Boston Scientific to buy Penumbra in $14.5 billion deal (Reuters)
07:00AM	Boston Scientific announces agreement to acquire Penumbra, Inc. (PR Newswire)
Jan-14-26 11:05AM	KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery (Zacks)
10:48AM	Reasons to Retain TransMedics Stock in Your Portfolio for Now (Zacks)
10:44AM	Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety (Zacks)
10:13AM	The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic (Zacks)
07:50AM	Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? (Zacks)
07:19AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? (Zacks)
Jan-13-26 07:00PM	JPM26: Boston Scientific expects strong PFA performance for 2026 and beyond (Medical Device Network)
01:40PM	3 MedTech Stocks Benefiting From Favorable Product Mix Shifts (Zacks)
01:01PM	JPM26: Boston Scientific strengthens urology portfolio with Valencia Technologies acquisition (Medical Device Network)
12:19PM	JPM26: Medtronic touts multi-billion dollar potential of key markets (Medical Device Network)
11:19AM	Brookdale Senior 4Q25 Sneak Peek: Occupancy Volume Rises to 82.5% (Zacks)
07:48AM	What's Powering J&J's MedTech Growth Ahead of Q4 Release? (Zacks)
Jan-12-26 06:00PM	Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
09:56AM	GeneDx Partners With Komodo Health to Advance Rare Disease Research (Zacks)
09:23AM	Boston Scientific to buy incontinence device maker Valencia (MedTech Dive)
08:09AM	Illumina's New Connected Multiomics Platform Set to Boost Its Stock (Zacks)
07:00AM	Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation (PR Newswire)
Jan-09-26 11:40AM	PAHC vs. BSX: Which Stock Should Value Investors Buy Now? (Zacks)
11:20AM	PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities (Zacks)
10:53AM	SENS Stock Up as Eversense 365 Enters AID Market With twiist System (Zacks)
09:08AM	Is it the Right Time to Add STERIS Stock to Your Portfolio? (Zacks)
08:16AM	Haemonetics Expands Heart Surgery Arsenal With Vivasure Acquisition (Benzinga)
Jan-08-26 09:46AM	INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite (Zacks)
08:29AM	Here's Why You Should Hold Avantor Stock in Your Portfolio for Now (Zacks)
08:27AM	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
07:57AM	Here's Why You Should Retain Cencora Stock in Your Portfolio Now (Zacks)
05:58AM	Boston Scientific Earnings Preview: What to Expect (Barchart)
Jan-07-26 12:11PM	ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves (Zacks)
12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio (Zacks)
09:50AM	Boston Scientific (BSX) Just Overtook the 50-Day Moving Average (Zacks)
08:30AM	If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You'd Have Now (Zacks)
Jan-06-26 06:15PM	Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
12:34PM	CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection (Zacks)
11:39AM	OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device (Zacks)
07:05AM	OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth (Zacks)
Jan-02-26 11:36AM	INBS Stock Surges 132.4% on New Manufacturing Partnership (Zacks)
08:00AM	Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results (PR Newswire)
Dec-31-25 10:52AM	Reasons to Hold HealthEquity Stock in Your Portfolio for Now (Zacks)
10:49AM	CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform (Zacks)
07:31AM	Here's Why You Should Retain CONMED Stock in Your Portfolio Now (Zacks)
07:21AM	How Is Boston Scientific's Cardiovascular Growth Path Shaping Up? (Zacks)
Dec-30-25 12:45PM	ESTA Shares Dip Despite FDA Filing for Motiva Breast Reconstruction (Zacks)
08:20AM	BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? (Zacks)
Dec-29-25 11:42AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
10:57AM	Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA (Zacks)
Dec-26-25 08:49AM	A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook (Insider Monkey)
Dec-24-25 12:29PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
08:40AM	How Well Is Boston Scientific Placed for Long-Term Endoscopy Growth? (Zacks)
08:05AM	Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? (Motley Fool)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Option Exercise	24.81	17,313	429,491	40,913	Dec 02 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Sale	101.55	17,313	1,758,189	23,600	Dec 02 05:04 PM
ARTHUR C BUTCHER	Officer	Dec 01 '25	Proposed Sale	101.55	17,313	1,758,188		Dec 01 04:02 PM
Zane Ellen M	Director	Nov 06 '25	Sale	98.28	12,891	1,266,978	24,134	Nov 06 04:34 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Nov 04 04:15 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Sale	99.47	50,000	4,973,338	178,342	Nov 04 04:15 PM
JOSEPH M FITZGERALD	Officer	Nov 03 '25	Proposed Sale	99.47	50,000	4,973,335		Nov 03 04:05 PM
Zane Ellen M	Director	Oct 27 '25	Sale	101.13	9,990	1,010,301	27,035	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Sale	102.24	2,901	296,599	24,134	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Proposed Sale	102.24	2,901	296,592		Oct 28 10:55 AM
Zane Ellen M	Director	Oct 27 '25	Proposed Sale	100.91	9,990	1,008,081		Oct 27 10:50 AM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Oct 01 04:22 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Sale	98.47	50,000	4,923,327	178,342	Oct 01 04:22 PM
JOSEPH M FITZGERALD	Officer	Oct 01 '25	Proposed Sale	98.47	50,000	4,923,325		Oct 01 04:04 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience